National Health Investors Inc

Because structural Stage 2 and Lockout Rally indicate strong momentum in a secular uptrend, and the breakout above key EMAs confirms institutional urgency, immediate participation is warranted despite overbought conditions. Use momentum continuation interaction rather than waiting for a pullback.

• ↑Q3 2025 revenue up 28% YoY, driven by SHOP platform conversions
• ↑Normalized FFO guidance raised 6.1% to $4.71/sh, backing dividend stability
• ↓Profitability lags, with legacy same-store performance below targets